Evidence map›Paper›PMID 34728900›Full record

ArticleEuropean journal of plastic surgery2022

New perspectives in regenerative medicine and surgery: the bioactive composite therapies (BACTs).

Michele L Zocchi, Federico Facchin, Andrea Pagani, Claudia Bonino, Andrea Sbarbati, Giamaica Conti, Vincenzo Vindigni, Franco Bassetto

Open access · hybridAbstract read
In one paragraph

Article in European journal of plastic surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Michele L ZocchiPlastic and Reconstructive Surgery Unit, University of Padua, Padua, Italy.
Federico FacchinPlastic and Reconstructive Surgery Unit, University of Padua, Padua, Italy.
Andrea PaganiDepartment of Plastic and Hand Surgery, Technical University of Munich, Munich, Germany.
Claudia BoninoDepartment of Rheumatology and Immune Diseases, Humanitas Gradenigo Hospital, Turin, Italy.
Andrea SbarbatiInstitute of Human Anatomy, University of Verona, Verona, Italy.
Giamaica ContiInstitute of Human Anatomy, University of Verona, Verona, Italy.
Vincenzo VindigniPlastic and Reconstructive Surgery Unit, University of Padua, Padua, Italy.
Franco BassettoPlastic and Reconstructive Surgery Unit, University of Padua, Padua, Italy.
University of Padua · ITUniversity of Verona · ITOspedale Humanitas Gradenigo · ITTechnical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regenerative medicine and surgery is a rapidly expanding branch of translational research in tissue engineering, cellular and molecular biology. To date, the methods to improve cell intake, survival, and isolation need to comply with a complex and still unclear regulatory frame, becoming everyday more restrictive and often limiting the effectiveness and outcome of the therapeutic choices. Thus, the authors developed a novel 360° regenerative strategy based on the synergic action of several new components called the bioactive composite therapies (BACTs) to improve grafted cells intake, and survival in total compliance with the legal and ethical limits of the current regulatory frame. The rationale at the origin of this new technology is based on the evidence that cells need supportive substrate to survive in vitro and this observation, applying the concept of translational medicine, is true also in vivo. Bioactive composite mixtures (BACMs) are tailor-made bioactive mixtures containing several bioactive components that support cells' survival and induce a regenerative response in vivo by stimulating the recipient site to act as an in situ real bioreactor. Many different tissues have been used in the past for the isolation of cells, molecules, and growth factors, but the adipose tissue and its stromal vascular fraction (SVF) remains the most valuable, abundant, safe, and reliable source of regenerative components and particularly of adipose-derived stems cells (ADSCs). The role of plastic surgeons as the historical experts in all the most advanced techniques for harvesting, manipulating, and grafting adipose tissue is fundamental in this constant process of expansion of regenerative procedures. In this article, we analyze the main causes of cell death and the strategies for preventing it, and we present all the technical steps for preparing the main components of BACMs and the different mixing modalities to obtain the most efficient regenerative action on different clinical and pathological conditions. The second section of this work is dedicated to the logical and sequential evolution from simple bioactive composite grafts (BACGs) that distinguished our initial approach to regenerative medicine, to BACTs where many other fundamental technical steps are analyzed and integrated for supporting and enhancing the most efficient regenerative activity. Level of Evidence: Not gradable.

Indexed as

Adipose-derived stem cells (ADSCs)Amino acids (AA)Bioactive composite mixtures (BACMs)Blood components (BCs)Cellular components (CCs)Cytokine modulationDelayed harvestingDonor site preparationMinimal grade manipulation (MGM)Muse cellsPhotobiostimulationPlatelet-rich fibrin (PRF)Programmed cell death (PCD)Reduced glutathione (GSH)REMIXROS antagonismStromal vascular fraction (SVF)Vitamins

Identifiers

PMID34728900
PMCPMC8554210
OpenAlexW3208238743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.